logo oncology-news

Онкология  >  Новости онкологии

При финансовой поддержке logo MSD Oncology

FDA approves maintenance olaparib-bevacizumab for HRD-positive advanced ovarian cancer

FDA also approved companion test based on randomized, phase 3 PAOLA-1 trial.